Clinical Utility of Combined Optical Genome Mapping and 523-gene Next Generation Sequencing Panel For Comprehensive Evaluation of Myeloid Cancers.
Nikhil Sahajpal, Ashis Kumar Mondal, Sudha Ananth, Daniel Saul, Soheil Shams, Alex R. Hastie, Natasha M. Savage, Vamsi K Kota, Alka Chaubey, Ravindra B Kolhe
This study evaluates the clinical utility of optical genome mapping and a 523-gene NGS panel for comprehensive genomic profiling of myeloid cancers, showing higher sensitivity and resolution compared to standard-of-care methods.
medRxiv · Jan 15, 2022 · PreprintGenetic & Genomic Medicine